[Characterization of PIK3CA/AKT1/PTEN gene mutations in hormone receptor- positive/HER2-negative breast cancer].
Minling Liu(Genesis Foundation), Xiaofeng Zeng(Ministry of Education of the People's Republic of China), Kong M. Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuying Liu(Tianjin University of Science and Technology), Xiaodong Huang(Zhejiang Chinese Medical University), Shafei Wu, Lingmin Zeng(Chinese Academy of Medical Sciences & Peking Union Medical College), X D Liu(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 0
Related Papers
Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|1.7k
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|1.7k
Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome
|Science Immunology|2020|555
Tumor-Repopulating Cells Induce PD-1 Expression in CD8+ T Cells by Transferring Kynurenine and AhR Activation
|Cancer Cell|2018|535
Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype
|Nature Communications|2018|520